Results Snapshot
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Jun 2026 is 71.19% vs 1,357.53% in Jun 2025
Consolidate Net Profit
YoY Growth in quarter ended Jun 2026 is -36.88% vs 72.17% in Jun 2025
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Jun 2026 is -19.44% vs 71.16% in Jun 2025
Interest
YoY Growth in quarter ended Jun 2026 is 139.39% vs -10.81% in Jun 2025
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Jun 2026 has improved from Jun 2025
Compare Quarterly Results Of Madrigal Pharmaceuticals, Inc. With
Quarterly - Net Sales
QoQ Growth in quarter ended Jun 2026 is 17.03% vs -3.05% in Mar 2026
YoY Growth in quarter ended Jun 2026 is 71.19% vs 1,357.53% in Jun 2025
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Jun 2026 is 38.67% vs -61.09% in Mar 2026
YoY Growth in quarter ended Jun 2026 is -36.88% vs 72.17% in Jun 2025
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Jun 2026 is 39.44% vs -55.91% in Mar 2026
YoY Growth in quarter ended Jun 2026 is -19.44% vs 71.16% in Jun 2025
Quarterly - Interest
QoQ Growth in quarter ended Jun 2026 is 1.28% vs -6.02% in Mar 2026
YoY Growth in quarter ended Jun 2026 is 139.39% vs -10.81% in Jun 2025
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Jun 2026 has improved from Mar 2026
YoY Growth in quarter ended Jun 2026 has improved from Jun 2025






